Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Meningococcal Diphtheria Toxoid Vaccine · 1 trial · 2 indications
Functional antibody activity against the meningococcal serogroups A, C, Y, and W-135 antigens contained in Menactra vaccine was measured using a SBA-HC assay. Seroprotection was defined as antibody titers ≥ 1:8.
| Arm | Type | Description |
|---|---|---|
| Meningococcal Diphtheria Toxoid Vaccine | EXPERIMENTAL | Participants at age 9 to 17 months of enrollment will receive 2 doses on Menactra vaccine at 3 to 6 months apart |
| Name | Type | Description |
|---|---|---|
| Meningococcal Diphtheria Toxoid Vaccine | BIOLOGICAL | 0.5 mL, Intramuscular |
Inclusion Criteria: * Male and female subjects aged 9 to 17 months on the day of inclusion * Informed consent form has been signed and dated by the parent(s) or other legally acceptable representative(s) (if applicable) * Subject and parent/legally acceptable representative (if applicable) able to ...
Meningococcal Diphtheria Toxoid Vaccine is used for the prevention of meningitis and meningococcal infection. It is an investigational vaccine being developed by Sanofi (SNY) and is currently in Phase 3 clinical development.
Sanofi (SNY) is developing Meningococcal Diphtheria Toxoid Vaccine. The vaccine is currently in Phase 3 clinical development for the prevention of meningitis and meningococcal infection.
Meningococcal Diphtheria Toxoid Vaccine is in Phase 3 clinical development. It is an investigational vaccine and has not been approved by regulatory authorities. One Phase 3 trial has been completed.
Meningococcal Diphtheria Toxoid Vaccine has one completed Phase 3 trial, NCT01890759, which evaluated immunogenicity and safety in subjects aged 9 to 23 months in India and the Russian Federation. The trial enrolled 300 participants and was uncontrolled.
The completed clinical trial NCT01890759 evaluated the Menactra vaccine, which is a meningococcal diphtheria toxoid vaccine. This trial assessed the immunogenicity and safety of Menactra in subjects aged 9 to 23 months in India and Russia.